Platform Technology Continue To Make Clinical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Platform technology continue to make clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Platform Technology Continue To Make Clinical Today - Breaking & Trending Today

Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results


Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results
Licensing Partners Leveraging PolyXen® Platform Technology Continue To Make Clinical, Regulatory and Commercial Advancement
FRAMINGHAM, MA / ACCESSWIRE /
May 12, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ( Xenetic or the Company ), a biopharmaceutical company focused on advancing XCART, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, today reported its financial results for the first quarter of 2021 and provided a corporate update.
During the first quarter our focus remained on advancing the development of our XCART platform, which we believe has the potential to provide a personalized CAR T therapy targeting cancers with a patient-and tumor-specific approach. The commencement of our exploratory patient biopsy trial is a key component of our preclinical development strategy and an important step forward toward advancing into a Phas ....

United States , Jenene Thomas , Jeffrey Eisenberg , Xenetic Biosciences , Platform Technology Continue To Make Clinical , Xenetic Biosciences Inc , Tm Platform Technology Overview , Platform Technology , Company Commissioned Market , Scripps Research , Takeda Pharmaceuticals Co , Continued Execution , Xcart Development Plan With Commencement , Company To Conduct Ind Enabling Studies , Partners Leveraging Polyxen , Chief Executive Officer , Technology Overview , Eastern Europe , B Cell Non Hodgkin , License Agreement , Takeda Pharmaceuticals , Financial Results , First Quarter , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப்ரி ஐசன்பெர்க் ,